Nicox Initiates Phase 2 Trial of NCX 4251 in Blepharitis
Go back to Nicox Initiates Phase 2 Trial of NCX 4251 in Blepharitis| (NYSE: COX) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 0 | |||||
